MRSN icon

Mersana Therapeutics
MRSN

Overview Fund Activity

135 hedge funds and large institutions have $1.28B invested in Mersana Therapeutics in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+5
Holders Change %
+3.85%
% of All Funds
2.73%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.16%
New
26
Increased
55
Reduced
37
Closed
21
Calls
$8.81M
Puts
$2.97M
Net Calls
+$5.83M
Net Calls Change
-$787K

Top Buyers

1
Alkeon Capital Management
1
Alkeon Capital Management
New York
$28.9M
2
State Street
2
State Street
Massachusetts
$54.9M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$34M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$19.4M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$70.6M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$64.6M
2
NMC
2
NEA Management Company
Maryland
$111M
3
MWNA
3
Marshall Wace North America
New York
$0
4
O
4
OrbiMed
New York
$24.7M
5
MIM
5
Monashee Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PHK
151
Point72 Hong Kong
Hong Kong
– -$139K -238 Closed
NIT
152
NumerixS Investment Technologies
British Columbia, Canada
– -$68K -116 Closed
Simplex Trading
153
Simplex Trading
Illinois
– -$41K -71 Closed
LC
154
Lindbrook Capital
California
– -$12K -20 Closed
Fidelity International
155
Fidelity International
Bermuda
– -$8K -13 Closed
3 4 5 6
7